Renalytix AI plc

RENX · LSE · Healthcare / Health Information Services

5.40GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close5.40

Open5.40

Day Range5.28 – 5.60

52-Week Range1.60 – 10.00

Volume193.36K

Market Cap40.23M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.03

Dividend Yield0.00%

Beta1.61

50-Day Avg4.62

200-Day Avg3.52

About

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company's products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize its products in connection with the application of artificial intelligence for the diagnosis of kidney disease. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in London, the United Kingdom.

Company Details

SectorHealthcare
IndustryHealth Information Services
CEOMr. James R. McCullough M.B.A.
Employees46
Headquarters2 Leman Street, London, United Kingdom, E1W 9US, UK
Websitehttps://renalytix.com

Leadership

Mr. James R. McCullough M.B.A.CEO & Director · b. 1968
Mr. Fergus FlemingCTO & Executive Director · b. 1967
Mr. Howard B. Doran Jr.President · b. 1961
Mr. Joel R. Jung MBAChief Financial Officer · b. 1958
Dr. Michael J. Donovan M.D., Ph.D.Chief Medical Officer · b. 1954

Financials

Income Statement

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2018-01-01	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2023-12-31	2024-06-30	2025-06-30
Total Revenue	67.67B	68.58B	58.63B	57.86B	55.48B	64.45B	-	0	58.31B	1.49M	2.97M	3.40M	59.60B	2.29M	3.00M
Growth (%)	-	+1.34%	-14.51%	-1.32%	-4.11%	+16.16%	-	-	-	-100.00%	+99.20%	+14.58%	+1751413.37%	-100.00%	+31.06%
Cost of Revenue	40.25B	40.03B	34.36B	33.46B	31.82B	36.57B	-	30.99K	74.00K	858.00K	2.05M	2.70M	34.43B	2.13M	1.80M
Gross Profit	27.42B	28.55B	24.27B	24.40B	23.66B	27.87B	-	-30.99K	-74.00K	633.00K	874.00K	701.00K	25.18B	156.00K	1.20M
Gross Margin	40.52%	41.63%	41.39%	42.17%	42.65%	43.25%	-	-	-0.00%	42.45%	29.43%	20.60%	42.24%	6.82%	40.00%
Operating Expense	18.41B	18.38B	14.72B	16.37B	15.55B	16.59B	-	42.31M	10.24M	32.55M	54.06M	43.06M	15.11B	29.76M	18.40M
Operating Income	9.01B	10.17B	9.55B	8.03B	8.11B	11.28B	-418.00K	-42.34M	-10.31M	-31.92M	-53.18M	-42.35M	10.07B	-29.61M	-17.20M
Operating Margin	13.31%	14.83%	16.28%	13.88%	14.62%	17.51%	-	-	-0.02%	-2140.58%	-1790.67%	-1244.64%	16.89%	-1293.49%	-573.33%
EBITDA	10.59B	11.75B	10.91B	9.52B	9.65B	13.13B	-418.00K	-6.87M	-10.24M	-32.69M	-52.69M	-41.71M	11.06B	-28.52M	-21.30M
EBITDA Margin	15.65%	17.14%	18.61%	16.45%	17.40%	20.37%	-	-	-0.02%	-2192.42%	-1774.21%	-1225.77%	18.55%	-1246.00%	-710.00%
Net Income	5.76B	6.67B	6.26B	5.33B	5.46B	7.23B	-1.25M	-42.30M	-9.84M	-34.73M	-45.28M	-45.61M	6.49B	-33.46M	-20.40M
Net Income Margin	8.51%	9.72%	10.68%	9.21%	9.83%	11.21%	-	-	-0.02%	-2328.97%	-1524.44%	-1340.20%	10.88%	-1461.60%	-680.00%
R&D	1.32B	1.43B	1.16B	1.09B	1.03B	1.08B	-	39.60M	4.57M	10.04M	14.65M	14.30M	949.00M	9.39M	900.00K
R&D as % of Total Revenue	1.95%	2.09%	1.97%	1.89%	1.86%	1.68%	-	-	0.01%	673.37%	493.20%	420.16%	1.59%	410.22%	30.00%
Interest Expense	511.57M	523.31M	392.18M	344.28M	371.54M	625.07M	-	20.00K	2.00K	3.00K	2.00K	2.00K	-	0	500.00K
Interest Expense % of Total Revenue	0.76%	0.76%	0.67%	0.60%	0.67%	0.97%	-	-	0.00%	0.20%	0.07%	0.06%	-	0.00%	16.67%

Balance Sheet

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2018-01-01	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2023-12-31	2024-06-30	2025-06-30
Total Assets	60.90B	62.68B	58.13B	56.80B	59.39B	-	56.63K	28.92M	41.30M	102.58M	50.06M	30.63M	75.27B	7.97M	6.10M
Total Liabilities	39.87B	42.28B	40.87B	39.33B	41.52B	-	66.02K	755.00K	5.34M	7.48M	19.46M	23.66M	54.50B	15.83M	13.10M
Total Equity	28.28B	28.85B	25.47B	25.09B	24.91B	-	-349.00K	8.55M	15.91M	71.46M	30.61M	6.97M	18.10B	-7.85M	-7.00M
Cash	3.25B	3.15B	2.60B	2.50B	3.56B	-	41.55K	9.29M	13.29M	65.16M	41.33M	24.68M	4.16B	4.68M	3.60M
Total Debt	-	-	-	-	-	-	66.02K	-	622.00K	352.00K	12.34M	12.15M	29.29B	8.54M	8.30M
Net Debt	-3.25B	-3.15B	-2.60B	-2.50B	-3.56B	-	24.47K	-9.29M	-12.67M	-64.81M	-28.99M	-12.53M	25.13B	3.85M	4.70M

Cash Flow

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2018-01-01	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2023-12-31	2024-06-30	2025-06-30
Operating Cash Flow	9.01B	6.29B	5.54B	7.33B	7.05B	7.88B	-422.00K	-6.16M	-10.06M	-24.63M	-45.74M	-32.67M	9.43B	-30.11M	-17.90M
Investing Cash Flow	-	-	-	-	-	-	-	-12.30M	-849.00K	-751.00K	-662.00K	-	-	-4.00K	-
Financing Cash Flow	-8.73B	-5.39B	-5.19B	-3.03B	-3.07B	-2.02B	504.00K	27.38M	16.54M	77.24M	25.52M	15.12M	-7.19B	10.25M	16.00M
Capital Expenditure	2.60B	1.79B	1.89B	1.87B	1.80B	1.51B	0	13.05M	1.31M	1.63M	694.00K	694.00K	1.50B	4.00K	6.29
Free Cash Flow	6.41B	4.50B	3.65B	5.46B	5.24B	6.37B	-422.00K	-17.04M	-11.37M	-26.26M	-46.44M	-33.37M	7.92B	-30.11M	-17.90M
Dividends Paid	3.56B	2.99B	3.19B	3.33B	3.61B	3.92B	-	4.66B	4.72B	5.23B	5.10B	4.64B	4.36B	-	-
FCF to OCF	71.11%	71.54%	65.85%	74.53%	74.40%	80.85%	100.00%	276.85%	113.04%	106.62%	101.52%	102.12%	84.07%	100.01%	100.00%
Dividend Paid to FCF	55.52%	66.47%	87.37%	60.97%	68.83%	61.48%	-	-27331.08%	-41512.85%	-19904.11%	-10987.39%	-13891.75%	55.06%	-	-

Earnings

Report Date	Oct 27, 2020	Mar 2, 2021	Jun 15, 2021	Dec 7, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Nov 30, 2022	Mar 30, 2023	Jun 9, 2023	Sep 28, 2023	Nov 14, 2023	Feb 15, 2024	May 15, 2024	Oct 1, 2024	Mar 18, 2025	Jun 17, 2025	Nov 4, 2025	May 13, 2026
EPS Estimate	0.00	0.00	-0.07	-0.07	-0.21	-0.20	-0.09	-0.09	-0.07	-0.06	-0.06	-0.06	-0.05	-0.04	-0.02	-0.01	-0.01	-0.01	0.00
EPS Actual	0.00	-0.12	-0.12	-0.14	-0.21	-0.20	-0.15	-0.04	-0.07	-0.07	-0.06	-0.06	-0.04	-0.06	-3.63	-0.91	0.00	0.00	0.00
Surprise	-	-	-65.52%	-109.90%	0.00%	0.00%	-68.44%	61.11%	-2.49%	-13.45%	-1.87%	13.11%	12.96%	-48.10%	-18059.50%	-5997.33%	100.00%	100.00%	-
Timing	-	-	-	-	Pre-market	Pre-market	-	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	After-hours	Pre-market	Pre-market	-	-	-

Key Statistics & Ratios

Market Cap40.23M

Enterprise Value35.93M

Trailing P/E0.00

Forward P/E0.00

Price / Sales12.19

Price / Book8.06

EPS-0.03

Book Value-0.0022

Revenue (TTM)3.30M

Gross Profit (TTM)1.50M

EBITDA-16.80M

Profit Margin0.00%

Operating Margin-437.50%

Return on Equity-1073.18%

Return on Assets-160.99%

Shares Outstanding670.46M

Shares Float306.12M

Beta1.61

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%